Assertion: plaque psoriasis | /r/HasProperty | candidate
Facets:
value: for phototherapy
type: PURPOSE
value: for systemic therapy
type: PURPOSE
Source sentences:
text: It’s intended for people with moderate to severe plaque psoriasis who are candidates for phototherapy (light therapy) or systemic (body-wide) therapy.
text: It can be used for young people with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
text: Amevive is indicated for adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
text: Amevive is indicated for adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
text: It has been approved for treatment of adults with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
text: It has been approved for treatment of adults with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
text: Humira is indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
text: Humira is indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
text: : Raptiva is indicated for the treatment of adult patients (18 or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
text: Raptiva is indicated for the treatment of adult patients (18 or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.